CD274 and non-small cell lung carcinoma: In order to examine whether zosuquidar can down‐regulate PD‐L1 expression in vivo condition, the NSCLC cell line NCI‐H292 was subcutaneously inoculated into nude mice and zosuquidar (90 mg kg−1) was orally administered daily for 10 d.